Skip to content
Home » IDDK Co., Ltd. IDDK Co., Ltd., which provides space bio-experiment services, raised 240 million yen in pre-series A first close.

IDDK Co., Ltd. IDDK Co., Ltd., which provides space bio-experiment services, raised 240 million yen in pre-series A first close.

IDDK Co., Ltd.
IDDK Co., Ltd., which provides space bio-experiment services, raises 240 million yen in pre-series A first close.
The total amount of equity raised since the seed round is 450 million yen. ……
IDDK Co., Ltd. (Representative Director: Soichiro Ueno, Headquarters: Koto-ku, Tokyo; hereinafter referred to as IDDK), which provides space bio-experiment services utilizing the proprietary semiconductor sensor-based microscopic observation technology MID, will Pre-series A first through third-party allotment of capital to Space Frontier Investment Limited Partnership (Sparks Innovation for Future Co., Ltd.) and Samurai Incubate Fund No. 7 Investment Limited Partnership (Samurai Incubate Co., Ltd.). At the closing, we raised 240 million yen (including the issuance of J-KISS type stock acquisition rights). This procurement brings the total amount of equity raised to 450 million yen. We plan to use the funds raised this time to develop next-generation MID and strengthen our system.
[Image 1

Funding background
IDDK has successfully developed an innovative microscopic observation technology (MID) (micro-imaging device) with a completely different principle from conventional microscopes through the fusion of optical technology and semiconductor technology. We are proceeding with the development of.
Aiming to build Japan’s first private sector-led space bio experiment platform using a satellite in low Earth orbit, demonstration experiments will begin in 2024, and services will begin in 2025, creating a microscope that can be used “anytime,” “anywhere,” and “by anyone.” We provide observation technology MID to all kinds of customers in special environments such as microgravity, even in space. Additionally, with a view to developing a commercial space station platform in anticipation of the retirement of the International Space Station (ISS) in 2030, we aim to develop new customers and expand the market for space applications, with a focus on bio-experiments in outer space.
[Image 2

Sparks Innovation for Future Co., Ltd. Representative Director and President Shinichiro Mikasa
“Ahead of the end of ISS operations in 2030, there is a growing movement to create opportunities for experiments such as microgravity in outer space using commercial space stations and artificial satellites.In this movement, IDDK’s MID technology We hope that IDDK will be able to cultivate new customers who have had difficulty utilizing bio-experiments in microgravity environments.In creating microgravity experiment opportunities in space towards the latter half of the 2020s, IDDK will We hope that you will explore the frontiers of the new space industry.”

Samurai Incubate Co., Ltd. Representative Director Kentaro Sakakibara [Image 4

Samurai Incubate Co., Ltd. Representative Director Kentaro Sakakibara “By privatizing space bio-experiments, we will provide a place to generate innovation for human problems that cannot be solved by ground-based research alone.” With the simplicity of our business scheme, and the team IDDK led by Mr. Ueno and Mr. Yoshioka, we are confident that we will be able to overcome any future business challenges and achieve our mission. This is our first investment in space-related services, and we look forward to taking on this big challenge together. We look forward to your continued support.” Message from IDDK Co., Ltd.
Representative Director and CEO Soichiro Ueno
[Image 5

d53748-18-c5212c1caf4be78c79e7-5.jpg&s3=53748-18-094ae271d470d161f1c165d235a0f6e3-2025x2700.jpg
IDDK Director and CFO Kohei Yoshioka
“It is a great honor to be accompanied by all our reassuring investors.In the funding environment known as the winter startup era, we are blessed with our members who are resilient against adversity, and we are able to execute the pre-series A first close. I was able to do it.While speaking at panel sessions at space-related conferences overseas, I feel that the demand for bio-experiments in space is steadily increasing, especially in Europe and the United States.Our company is a platform for space-based bio-experiments. We will become a company and provide a place to generate innovation to solve human problems that cannot be solved by ground-based research alone.With this funding, we will develop next-generation MID, strengthen our system, and accelerate business development. Masu.”
About IDDK Co., Ltd.
Company name: IDDK Co., Ltd.
Head office location: 309 Asahi Building, 1-12-8 Tomioka, Koto-ku, Tokyo Representative Director: Soichiro Ueno
Business content: Research, development, manufacturing, and sales of microscopic observation equipment, development, manufacturing, and sales of microscopic observation peripheral technology
Established: June 2017
HP: https://iddk.co.jp
More details about this release:
https://prtimes.jp/main/html/rd/p/000000018.000053748.html



%d